Skip To Main Content
Yingyi He on Muck Rack

Yingyi He

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingyi

Contact Yingyi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Implementation of preemptive pharmacogenetic testing: progress, puzzles and priorities from an implementation science perspective

|
By Rong Hu, Biyun Guo, Junli Zhou, Zhiming Hong, Ping Yi Lin, Chunping Wu, Zhiyuan Chen, YUE WANG, Xiaofang Wang, Huiyan Huang, Hao Zheng, Yingyi He, Kaizhi Weng, Shuquan Zhuang
| Frontiers
Abstract Preemptive pharmacogenetics (PGx) testing, which leverages genetic variation to predict drug response and toxicity, represents a pivotal advancement in precision medicine. By predicting drug-gene interactions and guiding precision dosing, it demonstrates significant potential to enhance drug safety and efficacy. However, its integration into routine clinical practice still faces a substantial translational gap.
Open in Who Shared Issue with article?

Anti-CLL1 chimeric antigen receptor T cell therapy in children with relapsed/refractory acute myeloid leukemia

|
By Pengfei Wang, Zhuoyan Li, Yingyi He
| AACR Journal
Clinical Trial Brief Report Hui Zhang, Pengfei Wang, Zhuoyan Li, Yingyi He, Wenting Gan and Hua Jiang DOI: 10.1158/1078-0432.CCR-20-4543 Abstract Purpose: The survival rate of children with refractory/relapsed acute myeloid leukemia (R/R-AML) by salvage chemotherapy is minimal. Treatment with chimeric antigen receptor T cells (CAR-T) has emerged as a novel therapy to improve malignancies treatment.
Open in Who Shared Issue with article?
See all 2 articles